Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) EBT (2016 - 2025)

Jaguar Health (JAGX) has disclosed EBT for 11 consecutive years, with -$7.2 million as the latest value for Q3 2025.

  • On a quarterly basis, EBT fell 2.03% to -$7.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$30.9 million, a 12.85% increase, with the full-year FY2024 number at -$39.3 million, up 6.32% from a year prior.
  • EBT was -$7.2 million for Q3 2025 at Jaguar Health, up from -$8.0 million in the prior quarter.
  • In the past five years, EBT ranged from a high of -$5.0 million in Q4 2024 to a low of -$18.2 million in Q1 2022.
  • A 5-year average of -$10.5 million and a median of -$9.6 million in 2024 define the central range for EBT.
  • Peak YoY movement for EBT: tumbled 63.28% in 2021, then skyrocketed 46.02% in 2024.
  • Jaguar Health's EBT stood at -$14.3 million in 2021, then soared by 42.51% to -$8.2 million in 2022, then fell by 13.08% to -$9.3 million in 2023, then surged by 46.02% to -$5.0 million in 2024, then tumbled by 44.16% to -$7.2 million in 2025.
  • Per Business Quant, the three most recent readings for JAGX's EBT are -$7.2 million (Q3 2025), -$8.0 million (Q2 2025), and -$10.6 million (Q1 2025).